MASP2 haplotypes are associated with high risk of cardiomyopathy in chronic Chagas disease

Clinical Immunology

Volumn 140, Issue 1, 2011, Pages 63-70

  Boldt, Angelica B W ^a   Luz, Paola R ^a   Messias Reason, Iara J T ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Cardiomyopathy; Chagas disease; MASP2; PCR SSP; Polymorphism; Trypanosoma cruzi

Indexed keywords

FICOLIN; MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN ASSOCIATED SERINE PROTEASE 2; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CHAGAS DISEASE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 79958766754     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.03.008     Document Type: Article

References (37)

1. Lescure F.X., Le L.G., Freilij H., Develoux M., Paris L., Brutus L., Pialoux G. Chagas disease: changes in knowledge and management. Lancet Infect. Dis. 2010, 10:556-570.
2. Maguire J.H. Chagas' disease-can we stop the deaths?. N. Engl. J. Med. 2006, 355:760-761.
3. Rossi M.A., Tanowitz H.B., Malvestio L.M., Celes M.R., Campos E.C., Blefari V., Prado C.M. Coronary microvascular disease in chronic Chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms. PLoS. Negl. Trop. Dis. 2010, 4.
4. Cestari I., Ramirez M.I. Inefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cells. PLoS ONE 2010, 5:e9721.
5. Cestari I.S., Krarup A., Sim R.B., Inal J.M., Ramirez M.I. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi. Mol. Immunol. 2009, 47:426-437.
6. Aiello V.D., Reis M.M., Benvenuti L.A., Higuchi M.L., Ramires J.A., Halperin J.A. A possible role for complement in the pathogenesis of chronic chagasic cardiomyopathy. J. Pathol. 2002, 197:224-229.
7. Messias-Reason I.J., Urbanetz L., Pereira da C.C. Complement C3 F and BF S allotypes are risk factors for Chagas disease cardiomyopathy. Tissue Antigens 2003, 62:308-312.
8. Luz P.R., Miyazaki M.I., Neto N.C., Nisihara R.M., Messias-Reason I.J. High levels of mannose-binding lectin are associated with the risk of severe cardiomyopathy in chronic Chagas Disease. Int. J. Cardiol. 2010, 143:448-450.
9. Stover C.M., Thiel S., Thelen M., Lynch N.J., Vorup-Jensen T., Jensenius J.C., Schwaeble W.J. Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J. Immunol. 1999, 162:3481-3490.
10. Takahashi M., Endo Y., Fujita T., Matsushita M. A truncated form of mannose-binding lectin-associated serine protease (MASP)-2 expressed by alternative polyadenylation is a component of the lectin complement pathway. Int. Immunol. 1999, 11:859-863.
11. Stover C., Endo Y., Takahashi M., Lynch N.J., Constantinescu C., Vorup-Jensen T., Thiel S., Friedl H., Hankeln T., Hall R., Gregory S., Fujita T., Schwaeble W. The human gene for mannan-binding lectin-associated serine protease-2 (MASP-2), the effector component of the lectin route of complement activation, is part of a tightly linked gene cluster on chromosome 1p36.2-3. Genes Immun. 2001, 2:119-127.
12. Stengaard-Pedersen K., Thiel S., Gadjeva M., Moller-Kristensen M., Sorensen R., Jensen L.T., Sjoholm A.G., Fugger L., Jensenius J.C. Inherited deficiency of mannan-binding lectin-associated serine protease 2. N. Engl. J. Med. 2003, 349:554-560.
13. Thiel S., Steffensen R., Christensen I.J., Ip W.K., Lau Y.L., Reason I.J., Eiberg H., Gadjeva M., Ruseva M., Jensenius J.C. Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes Immun. 2007, 8:154-163.
14. Valles X., Sarrias M.R., Casals F., Farnos M., Piner R., Suarez B., Morais L., Mandomando I., Sigauque B., Roca A., Alonso P.L., Torres A., Thielens N.M., Lozano F. Genetic and structural analysis of MBL2 and MASP2 polymorphisms in south-eastern African children. Tissue Antigens 2009, 74:298-307.
15. Thiel S., Kolev M., Degn S., Steffensen R., Hansen A.G., Ruseva M., Jensenius J.C. Polymorphisms in mannan-binding lectin (MBL)-associated serine protease 2 affect stability, binding to MBL, and enzymatic activity. J. Immunol. 2009, 182:2939-2947.
16. Secretaria de Vigilância em Saúde do Ministério da Saúde Consenso Brasileiro em Doença de Chagas. Rev. Soc. Bras. Med. Trop. 2005, 38:1-29.
17. Boldt A.B., Petzl-Erler M.L. A new strategy for mannose-binding lectin gene haplotyping. Hum. Mutat. 2002, 19:296-306.
18. Boldt A.B., Culpi L., Tsuneto L.T., de Souza I.R., Kun J.F., Petzl-Erler M.L. Diversity of the MBL2 gene in various Brazilian populations and the case of selection at the mannose-binding lectin locus. Hum. Immunol. 2006, 67:722-734.
19. Junqueira C., Caetano B., Bartholomeu D.C., Melo M.B., Ropert C., Rodrigues M.M., Gazzinelli R.T. The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease. Expert Rev. Mol. Med. 2010, 12:e29.
20. Moller-Kristensen M., Thiel S., Sjoholm A., Matsushita M., Jensenius J.C. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway. Int. Immunol. 2007, 19:141-149.
21. Gulla K.C., Gupta K., Krarup A., Gal P., Schwaeble W.J., Sim R.B., O'Connor C.D., Hajela K. Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot. Immunology 2010, 129:482-495.
22. Thiel S. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol. Immunol. 2007, 44:3875-3888.
23. Cedzynski M., Szemraj J., Swierzko A.S., Bak-Romaniszyn L., Banasik M., Zeman K., Kilpatrick D.C. Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system. Clin. Exp. Immunol. 2004, 136:304-311.
24. Notarangelo L.D., Fischer A., Geha R.S., Casanova J.L., Chapel H., Conley M.E., Cunningham-Rundles C., Etzioni A., Hammartrom L., Nonoyama S., Ochs H.D., Puck J., Roifman C., Seger R., Wedgwood J. Primary immunodeficiencies: 2009 update. J. Allergy Clin. Immunol. 2009, 124:1161-1178.
25. St S.A., Cedzynski M., Domzalska-Popadiuk I., MacDonald S.L., Borkowska-Klos M., Atkinson A.P., Szala A., Jopek A., Jensenius J.C., Kawakami M., Szczapa J., Matsushita M., Szemraj J., Turner M.L., Kilpatrick D.C. Mannan-binding lectin-associated serine protease-2 (MASP-2) in a large cohort of neonates and its clinical associations. Mol. Immunol. 2009, 46:1696-1701.
26. Ytting H., Christensen I.J., Thiel S., Jensenius J.C., Nielsen H.J. Pre- and postoperative levels in serum of mannan-binding lectin associated serine protease-2 - a prognostic marker in colorectal cancer. Hum. Immunol. 2008, 69:414-420.
27. Nielsen R.G., Vind I., Munkholm P., Jensenius J.C., Thiel S., Steffensen R., Husby S. Genetic polymorphisms of mannan binding lectin (MBL), serum levels of MBL, the MBL associated serine protease and H-ficolin in patients with Crohn's disease. Gut 2007, 56:311-312.
28. Messias-Reason I., Bosco D.G., Nisihara R.M., Jakobsen L.H., Petzl-Erler M.L., Jensenius J.C. Circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease 2 in endemic pemphigus foliaceus. Clin. Exp. Dermatol. 2008, 33:495-497.
29. Schafranski M.D., Pereira F.L., Scherner D., Torres R., de Messias-Reason I.J. Functional MASP2 gene polymorphism in patients with history of rheumatic fever. Hum. Immunol. 2008, 69:41-44.
30. de Rooij B.J., van H.B., ten Hove W.R., Roos A., Bouwman L.H., Schaapherder A.F., Porte R.J., Daha M.R., van der Reijden J.J., Coenraad M.J., Ringers J., Baranski A.G., Hepkema B.G., Hommes D.W., Verspaget H.W. Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation. Hepatology 2010, 52:1100-1110.
31. Cervera C., Lozano F., Saval N., Gimferrer I., Ibanez A., Suarez B., Linares L., Cofan F., Ricart M.J., Esforzado N., Marcos M.A., Pumarola T., Oppenheimer F., Campistol J.M., Moreno A. The influence of innate immunity gene receptors polymorphisms in renal transplant infections. Transplantation 2007, 83:1493-1500.
32. Garcia-Laorden M.I., Garcia-Saavedra A., de Castro F.R., Violan J.S., Rajas O., Blanquer J., Borderias L., Rodriguez-Gallego C. Low clinical penetrance of mannose-binding lectin-associated serine protease 2 deficiency. J. Allergy Clin. Immunol. 2006, 118:1383-1386.
33. Schafranski M.D., Stier A., Nisihara R., Messias-Reason I.J. Significantly increased levels of mannose-binding lectin (MBL) in rheumatic heart disease: a beneficial role for MBL deficiency. Clin. Exp. Immunol. 2004, 138:521-525.
34. Schafranski M.D., Pereira F.L., Scherner D., Torres R., Jensenius J.C., de Messias-Reason I.J. High-producing MBL2 genotypes increase the risk of acute and chronic carditis in patients with history of rheumatic fever. Mol. Immunol. 2008, 45:3827-3831.
35. Duus K., Thielens N.M., Lacroix M., Tacnet P., Frachet P., Holmskov U., Houen G. CD91 interacts with mannan-binding lectin (MBL) through the MBL-associated serine protease-binding site. FEBS J. 2010, 277:4956-4964.
36. de Messias-Reason I., Kremsner P.G., Kun J.F. Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy. J. Infect. Dis. 2009, 199:801-804.
37. Boldt A.B., Luty A., Grobusch M.P., Dietz K., Dzeing A., Kombila M., Kremsner P.G., Kun J.F. Association of a new mannose-binding lectin variant with severe malaria in Gabonese children. Genes Immun. 2006, 7:393-400.